1 Genomics and the Human Condition Francis S. Collins, M.D., Ph.D. Dedication of Ken Olsen Science...
-
Upload
briana-osborne -
Category
Documents
-
view
221 -
download
0
Transcript of 1 Genomics and the Human Condition Francis S. Collins, M.D., Ph.D. Dedication of Ken Olsen Science...
1
Genomics and theHuman Condition
Francis S. Collins, M.D., Ph.D.
Dedication of Ken Olsen Science CenterGordon College
September 27, 2008
2
3
4
5
A SMALL SAMPLING OF COOL THINGS ABOUT THE GENOME
• Humans have fewer protein-coding genes than expected – only about 20,000
• Only about 1.5% of the human genome is involved in coding for protein, but there are numerous complex critical functions encoded in the rest of the DNA instruction book
• We are all >99% the same at the DNA level
6
Cystic fibrosis Adult onset diabetes AIDS
7Glazier et al., Science 298:2345-9, 2002
8
The candidate gene approach
9
The Genome Wide Association approach:Making every gene in the genome a candidate
10
200520062007 first quarter2007 second quarter2007 third quarter2007 fourth quarterFirst quarter 2008 Second quarter 2008
Manolio, Brooks, Collins, J. Clin. Invest., May 2008
11
http://cancergenome.nih.gov
12
What will be the impact of genomics on the
practice of medicine?
13
Diagnostics
Preventive Medicine
Disease with Genetic Component
Time
Accelerated by Human
Genome Projectand HapMap
Identify Genetic Risk Factors
14
Saving lives with genetic testingSaving lives with genetic testing
UterineCancer
48
UterineCancer
48
ColonCancer
51
ColonCancer
51
ColonCancer
56
ColonCancer
56
15
Diagnostics
Preventive Medicine
Disease with Genetic Component
Time
Accelerated by Human
Genome Projectand HapMap
Identify Genetic Risk Factors
Pharmacogenomics
16
Pharmacogenomics: Unlocking the Human Genome for Better Drug Therapy
McLeod & Evans, Ann Rev Pharmacol Toxicol 41:101-21, 2001
All patients with same diagnosis
Treat
Remove
No response
Toxic response
Responses without
toxic side effects
17
Diagnostics
TherapeuticDevelopments• Gene Therapy • Drug Therapy
Preventive Medicine
Disease with Genetic Component
Time
Accelerated by Human
Genome Projectand HapMap
Identify Genetic Risk Factors
Pharmacogenomics
18
Gleevec™ – Specifically Targets an Abnormal Protein,Blocking Its Ability to Cause Chronic Myeloid Leukemia
Leukemia
Leukemia Protein
Gleevec™
Leukemia Protein
Remission
Leukemia arises in mutated blood cell
19
20
21